Literature DB >> 12654686

Molecular characterization and antimicrobial susceptibility of fluoroquinolone-resistant or -susceptible Streptococcus pneumoniae from Hong Kong.

Ian Morrissey1, David J Farrell, Sarah Bakker, Sylvie Buckridge, David Felmingham.   

Abstract

Fluoroquinolone resistance in Streptococcus pneumoniae isolated from Hong Kong as part of Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin 1999/2000 was found to be due to the spread of the Spain(23F)-1 clone (mainly a Spain(23F)-1-14 variant). All the isolates were multidrug resistant but were susceptible to quinupristin-dalfopristin, linezolid, and telithromycin. The Spain(23F)-1 clone also occurred among antimicrobial-susceptible isolates, which suggests that the primary source of this clone may have been Asia rather than Iberia.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12654686      PMCID： PMC152518          DOI： 10.1128/AAC.47.4.1433-1435.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong.

Authors:  P L Ho; T L Que; D N Tsang; T K Ng; K H Chow; W H Seto
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Target site modifications and efflux phenotype in clinical isolates of Streptococcus pneumoniae from Hong Kong with reduced susceptibility to fluoroquinolones.

Authors:  P L Ho; W C Yam; T L Que; D N Tsang; W H Seto; T K Ng; W S Ng
Journal:  J Antimicrob Chemother       Date:  2001-05       Impact factor: 5.790

3.  Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.

Authors:  D J Hoban; G V Doern; A C Fluit; M Roussel-Delvallez; R N Jones
Journal:  Clin Infect Dis       Date:  2001-05-15       Impact factor: 9.079

4.  Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998.

Authors:  D F Sahm; M E Jones; M L Hickey; D R Diakun; S V Mani; C Thornsberry
Journal:  J Antimicrob Chemother       Date:  2000-04       Impact factor: 5.790

5.  Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates.

Authors:  P Descheemaeker; S Chapelle; C Lammens; M Hauchecorne; M Wijdooghe; P Vandamme; M Ieven; H Goossens
Journal:  J Antimicrob Chemother       Date:  2000-02       Impact factor: 5.790

6.  The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections.

Authors:  D Felmingham; R N Grüneberg
Journal:  J Antimicrob Chemother       Date:  2000-02       Impact factor: 5.790

7.  Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000.

Authors:  P L Ho; R W Yung; D N Tsang; T L Que; M Ho; W H Seto; T K Ng; W C Yam; W W Ng
Journal:  J Antimicrob Chemother       Date:  2001-11       Impact factor: 5.790

8.  Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin.

Authors:  David Felmingham; Ralf Rene Reinert; Yoichi Hirakata; Arne Rodloff
Journal:  J Antimicrob Chemother       Date:  2002-09       Impact factor: 5.790

9.  Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study.

Authors:  D J Farrell; I Morrissey; S Bakker; D Felmingham
Journal:  J Antimicrob Chemother       Date:  2002-09       Impact factor: 5.790

10.  A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease.

Authors:  Mark C Enright; Brian G Spratt
Journal:  Microbiology (Reading)       Date:  1998-11       Impact factor: 2.777
View more
  5 in total

1.  Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study.

Authors:  Steven D Brown; David J Farrell; Ian Morrissey
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

2.  Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005.

Authors:  Margaret Ip; Shirley S L Chau; Fang Chi; Edmund S C Cheuk; Helen Ma; Raymond W M Lai; Paul K Chan
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

3.  Genomic characterization of ciprofloxacin resistance in a laboratory-derived mutant and a clinical isolate of Streptococcus pneumoniae.

Authors:  Andréanne Lupien; Dewan S Billal; Fereshteh Fani; Hafid Soualhine; George G Zhanel; Philippe Leprohon; Marc Ouellette
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

4.  Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm(B)- and mef(A)-mediated macrolide resistance.

Authors:  David J Farrell; Ian Morrissey; Sarah Bakker; Louise Morris; Sylvie Buckridge; David Felmingham
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

5.  Activity of telithromycin and comparators against bacterial pathogens isolated from 1,336 patients with clinically diagnosed acute sinusitis.

Authors:  Joseph Dohar; Rafael Cantón; Robert Cohen; David John Farrell; David Felmingham
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-08-02       Impact factor: 3.944
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.